Home/Filings/4/0001162194-23-000010
4//SEC Filing

Davis Jeremy Steven 4

Accession 0001162194-23-000010

CIK 0001162194other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 9:45 PM ET

Size

8.3 KB

Accession

0001162194-23-000010

Insider Transaction Report

Form 4
Period: 2023-02-21
Davis Jeremy Steven
SVP Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-02-21+20,83320,833 total
  • Tax Payment

    Common Stock

    2023-02-21$2.03/sh6,176$12,53714,657 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-2120,833229,167 total
    Common Stock (20,833 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
  • [F2]On December 20, 2022, the Reporting Person was granted 250,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023.

Issuer

STANDARD BIOTOOLS INC.

CIK 0001162194

Entity typeother

Related Parties

1
  • filerCIK 0001919871

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 9:45 PM ET
Size
8.3 KB